| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015289227 |
| P356 | DOI | 10.1186/CC4860 |
| P932 | PMC publication ID | 1550917 |
| P698 | PubMed publication ID | 16584528 |
| P5875 | ResearchGate publication ID | 7194595 |
| P50 | author | Jose Garnacho-Montero | Q56867748 |
| P2093 | author name string | Rosario Amaya-Villar | |
| P2860 | cites work | Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome | Q24811601 |
| Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis | Q28217179 | ||
| The effects of injury on the adaptive immune response | Q33585398 | ||
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. | Q34455633 | ||
| Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance | Q34543381 | ||
| Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. | Q41791143 | ||
| Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients | Q41998776 | ||
| Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? | Q43561043 | ||
| Immunoparalysis as a cause for invasive aspergillosis? | Q43798573 | ||
| Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy | Q45172488 | ||
| Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. | Q54251450 | ||
| Invasive Pulmonary Aspergillosis in Patients with Chronic Obstructive Pulmonary Disease: Report of Eight Cases and Review | Q57238104 | ||
| Invasive aspergillosis | Q74492548 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| P433 | issue | 2 | |
| P921 | main subject | aspergillosis | Q259626 |
| critical illness | Q65807521 | ||
| P304 | page(s) | 132 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go! | |
| P478 | volume | 10 |
| Q46059175 | A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients |
| Q46977334 | A microdevice for rapid optical detection of magnetically captured rare blood pathogens. |
| Q40151306 | Indoor airborne fungal pollution in newborn units in Turkey. |
| Q38066616 | Invasive aspergillosis in the intensive care unit |
| Q33719459 | Invasive pulmonary aspergillosis in an immunocompetent patient with severe dengue fever |
| Q37263189 | Patients at high risk of invasive fungal infections: when and how to treat |
| Q31106825 | Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection? |
Search more.